Speakers / Chairs icon
Speakers / Chairs
Exhibition icon
Exhibition
Abstracts icon
Abstracts
Information icon
Information
Live icon
Live
Awards icon
Awards
Information icon
Information
Information icon
Information
Information icon
Information
Archive icon
Archive
Saturday 23.10.2010
Scientific Session
Satellite Symposium
Patiententag
Main Program
Workshop
calendar export icon
Export calendar
Treatment of Hodgkin Lymphoma: Comparison of Treatment Intensity and Ef cacy of Pediatric and Adult Protocols
Hodgkin Lymphoma in Adolescents: French Experience and Conclusions
Adolescents Are Biological Adults
Hodgkin Lymphoma in Adolescents and Young Adults Is Best Managed as an Adult Disease
Towards Standardization of Scanning and
Reporting of Results
Logistics of the Network of Imaging Exchange and the Review Panel
Interim PET and the Role of Radiotherapy in Early Stage Disease
Interim-PET in Tailoring Therapy in Early Stage HL – The EORTC-GELA-IIL Experience
Interim-PET in the Therapeutic Strategy of Advanced Stage HL
Interim-PET in Patients with Advanced HL Treated with Non-ABVD Regimens
Interim-PET During BEACOPP Chemotherapy: Experience of the GHSG
Molecular Cytogenetic Studies in Hodgkin Lymphoma
The role of KLF4 and FoxO1 in Hodgkin Lymphoma
JAK2 Rearrangements, Including the Novel SEC31A-JAK2 Fusion, Are Recurrent in Classical Hodgkin Lymphoma
HLA Expression and Genetic Associations in EBV Positive and EBV Negative Classical Hodgkin Lymphoma
Immune Escape in Hodgkin Lymphoma and PTLD – the Role and Targeting of Galectin-1
Epidemiology Trends of HL in Sweden
Methylation Pro ling of Mediastinal Gray Zone Lymphoma
DNA Methylation Analyses in Hodgkin Lymphoma
Mechanisms of Aberrant GATA-3 Expression in Classical Hodgkin Lymphoma
Genome-Wide Copy Number Analysis of Microdissected HRS Cells in Classical Hodgkin Lymphoma
The Optimal First Line treatment
Options in Subsequent Relapses
Radiotherapy Alone is Suf cient in Early Stage
Chemotherapy Should Be Added to Radiotherapy in Early Stage
Evidence for Radiotherapy in Early Stage Hodgkin Lymphoma, Volume and Dose – Review of the Meta-Analyses
Evidence for Radiotherapy in Advanced Stage Hodgkin Lymphoma, Volume and Dose
RT Dose in Early Stages – the GHSG Studies
Reductions in Irradiated Volume in Hodgkin Lymphoma, IFRT and INRT
Is INRT Suitable for Pediatric Patients?
Highly Conformal Radiotherapy for Hodgkin Lymphoma, IMRT, Arc Therapy, Proton Therapy
Imaging for Highly Conformal Radiotherapy for Hodgkin Lymphoma
Uncertainties in Highly Conformal Radiotherapy for Hodgkin Lymphoma
Panel Discussion and Proposal for an ‘International Forum for Lymphoma Radiation Oncologists’
Hodgkin Lymphoma in Non-Western Countries: Pathology
Hodgkin Lymphoma in Non-Western Countries: Africa
Hodgkin Lymphoma in Non-Western Countries: South America
Hodgkin Lymphoma in Non-Western Countries: Middle East
Hodgkin Lymphoma in Non-Western Countries: China
Response Assessment in Clinical Practice and Clinical Research
Experience with PET in Hodgkin Lymphoma
Current Risk Adapted Clinical Trials in Hodgkin Lymphoma
Recent Modi cations of the International Response Criteria for Lymphoma
New Directions in Imaging for Lymphoma
Sunday 24.10.2010
Scientific Session
Satellite Symposium
Patiententag
Main Program
Workshop
calendar export icon
Export calendar
Leukaemic Stem Cells: AML Show the Way
Cancer Stem Cells in Hodgkin Lymphoma
Aspects of the Relationship of Hodgkin and Reed/Sternberg Cells and Potential Precursor Cells
Classical Hodgkin Lymphoma Micro- environment. Pathologic Aspects and the Role of CD40 / CD40L
Gene and Micro-RNAs Signatures as Predictors of Risk in Hodgkin Lymphoma: Integrating Tumor and Microenvironment
Can Immunohistochemical Markers at Diagnosis Have the Same Predictive Value of Early Interim-PET in Classical Hodgkin Lymphoma?
Integrative Analysis Reveals Selective 9p24.1 Ampli cation, Increased PD-L1 Ligand Expression and Further Induction via JAK2 in Nodular Sclerosing Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma
Rational and Clinical Experiences with Lenalidomide in Hodgkin Lymphoma
Progress in CLL Treatment
Emerging Treatment Options for Mantle Cell Lymphoma
Clinical Gaps in the Treatment of Patients with Relapsed/Refractory Hodgkin Lymphoma
Targeting CD30 in Hodgkin Lymphoma
Ongoing Phase III Trials in Relapsed/Refractory Hodgkin Lymphoma
Panel Discussion: Optimizing the Path to Transplant for Patients with Late-Stage Hodgkin Lymphoma
Session details
16:00–17:30
Satellite Symposium
Novel Approaches in the Treatment of Hodgkin Lymphoma: Beyond Chemotherapy
Room: Großer Saal
DAC Inhibitors, a New Class of Compounds: Landscape and MOA
Evolution of Panobinostat in Treating Hodgkin Lymphoma
Novartis Pipeline: Investigational Compounds in Lymphoma
Bonadonna Lecture: The Role of Viral Infections in Hodgkin Lymphoma
Awards Ceremony
Monday 25.10.2010
Scientific Session
Satellite Symposium
Patiententag
Main Program
Workshop
calendar export icon
Export calendar
Rationale for Non-Genotoxic Treatment
From High Dimensional Data to Disease Mechanisms – NOTCH Signaling in Hodgkin Lymphoma
The Role of miRNAs in Hodgkin Lymphoma
Methylation Pro ling of Mediastinal Gray Zone Lymphoma Reveals a Distinctive Signature with Elements Shared by Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma
Actions Following the Interim Analysis of the EORTC/GELA/IIL Intergroup H10 Trial
Debate: Role of Radiotherapy in Early Favorable HL
State of the Art and Future Perspectives
Early FDG-PET Scan Con rms Its Prognostic Impact Also in Localized Stage, ABVD Treated Hodgkin Lymphoma Patients
Involved Node Radiotherapy Signi cantly Reduces Lung, Breast and Thyroid Dose in Patients with Limited Stage Hodgkin Lymphoma
Early Response-Based HL Therapies of the COG
Update on EuroNet-PHL-C1 trial
Hodgkin Lymphoma therapy in Central America
Involved Level 3-D Based Target Volume Concepts for Pediatric Hodgkin Lymphoma
Lunch
Chronic Lymphatic Leukemia
WS Report on Non-Western Countries
WS Report on HL Treatment of Adolescents
Hodgkin Lymphoma and HIV Infection (HD- HIV): Prognostic Factors in 596 Patients (Pts) within the European Group for the Study of HIV and Tumours
Feasibility and Ef cacy of ABVD in Elderly Hodgkin Lymphoma Patients: Analysis of Two Randomized Prospective Multicenter Trials of the German Hodgkin Study Group (HD10 and HD11)
Autologous Stem Cell Transplantation for Adolescents and Young Adults with Relapsed or Refractory Hodgkin Lymphoma
WS Report on Follow-Up Recommendations
Long-Term Outcome of Children and Adolescents
A Comprehensive Prospective National Database to Enhance Breast Cancer (BC) Screening Services for Hodgkin Lymphoma (HL) Survivors Treated with Supradiaphragmatic Radiotherapy (SRT) in England
A Prospective Study of Breast Magnetic Resonance Imaging (MRI) and Mammographic Screening in Long-Term Female Hodgkin Lymphoma (HL) Survivors
Coronary Artery Disease in Patients Treated for Hodgkin Lymphoma: Preliminary Results Using Computed Angiography Tomography
Mantle Cell Lymphoma – Quo Vadis?
Follicular Lymphoma – Bortezomib in the Relapsed/Refractory Setting
Tuesday 26.10.2010
Scientific Session
Satellite Symposium
Patiententag
Main Program
Workshop
calendar export icon
Export calendar
Long Term Outcome of High-Dose Salvage Therapy for Patients with Early Stage Hodgkin Lymphoma (HL) Who Failed Initial Treatment with Combined Modality Treatment or Chemotherapy Alone
Relapse of Hodgkin Lymphoma after Autologous Stem Cell Transplantation (ASCT): Identi cation of Prognostic Factors Predicting Outcome
Allogeneic Stem Cell Transplantation for Hodgkin Lymphoma: a Retrospective Analysis of Data from the German Stem cell Transplantation Registry (DRST)
Everolimus for Relapsed/Refractory HL
Extended Follow-Up of the Safety of
131I Radiolabelled Anti-CD25 Antibody, Basiliximab, in Patients with CD25-Positive, Refractory Hodgkin Lymphoma
Initial Results from the SAPHIRE Study: a Phase II Trial with the Novel Oral Histone Deacetylase (HDAC) Inhibitor Resminostat in Relapsed or Refractory Hodgkin Lymphoma Patients
Session details
12:00–13:15
Satellite Symposium
New Mobilisation Strategies in Autologous Stem Cell Transplantation
Room: Großer Saal
The Role and Challenges of Autologous Transplantation in Hodgkin Lymphoma
Optimizing Stem Cell Mobilization with Plerixafor in Hodgkin Lymphoma
Contribution of PET/CT in the Design of the Involved Node Radiotherapy (INRT) Concept for Patients with Localized Hodgkin Lymphoma: Preliminary Results on 117 Patients entered in the H10 Trial
Early Interim FDG-PET during Intensi ed BEACOPP Therapy for Advanced-Stage Hodgkin Lymphoma Shows a Lower Positive Predictive Value than during ABVD
A Bone Marrow Biopsy is Not Necessary in the Staging of Hodgkin Lymphoma (HL) Patients in the FDG-PET Era
Debate: Kairos or Chronos? Early versus Late Intensi cation in Advanced HL
Intensi ed ABVD for Newly Diagnosed Patients with Advanced-Stage Classical Hodgkin Lymphoma
BEACOPP is Superior to ABVD in Patients with Advanced Hodgkin Lymphoma and High Tumor Burden
Speaker details
Hamdy
Abdel Azim
Speaker details
Ranjana
Advani
Speaker details
Berthe
Aleman
Speaker details
Richard
Ambinder
Speaker details
James
Armitage
Speaker details
Abraham
Avigdor
Speaker details
Nancy
Bartlett
Speaker details
Neha
Bhatnagar
Speaker details
Magnus
Björkholm
Speaker details
Boris
Böll
Speaker details
Dominique
Bonnet
Speaker details
Peter
Borchmann
Speaker details
Pauline
Brice
Speaker details
Belinda
Campbell
Speaker details
George
Canellos
Speaker details
Antonio
Carbone
Speaker details
Patrice
Carde
Speaker details
Franco
Cavalli
Speaker details
Robert
Chen
Speaker details
Bruce
Cheson
Speaker details
Carlos
Chiattone
Speaker details
Teodoro
Chisesi
Speaker details
Joseph
Connors
Speaker details
Louis S.
Constine
Speaker details
Michael
Crump
Speaker details
Pedro
De Alarcon
Speaker details
Volker
Diehl
Speaker details
Markus
Dietlein
Speaker details
Bernd
Dörken
Speaker details
Peter
Dreger
Speaker details
Franziska
Eberle
Speaker details
Dennis
Eichenauer
Speaker details
Andreas
Engert
a.engert@uni-koeln.de
23.10.,
16:00–17:30,
HL in Non-Western Countries
(Chair)
24.10.,
14:00–15:00,
CD30 as a Target for Hodgkin Lymphoma
(Chair, Speaker)
24.10.,
16:00–17:30,
Novel Approaches in the Treatment of Hodgkin Lymphoma: Beyond Chemotherapy
(Chair, Speaker)
25.10.,
12:00–14:00,
State-of-the-Art and Future Approaches
(Chair)
26.10.,
17:30–19:00,
Closing Remarks
(Chair)
25.10.,
10:30–12:00,
Early Stages
(Speaker)
26.10.,
16:00–17:30,
Advanced Stage
(Speaker)
Speaker details
Francesca
Fiore
Speaker details
Richard
Fisher
Speaker details
Michael
Fuchs
Speaker details
Andrea
Gallamini
Speaker details
Juan F
García
Speaker details
Randy
Gascoyne
Speaker details
Michele
Ghielmini
Speaker details
Theodore
Girinsky
Speaker details
Christian
Gisselbrecht
Speaker details
Paolo
Gobbi
Speaker details
Anton
Hagenbeek
Speaker details
Michael
Hallek
Speaker details
Georg
Heß
Speaker details
Brad
Hoppe
Speaker details
Richard
Hoppe
Speaker details
Sache
Howell
Speaker details
Martin
Hutchings
Speaker details
Tim
Illidge
Speaker details
Wlodarska
Iwona
Speaker details
Peter
Jacobs
Speaker details
Elaine
Jaffe
Speaker details
Wenqi
Jiang
Speaker details
Peter
Johnson
Speaker details
Patrick
Johnston
Speaker details
Kara
Kelly
Speaker details
Karl
Köchert
Speaker details
Dieter
Körholz
Speaker details
Lale
Kostakoglu
Speaker details
Ralf
Küppers
Speaker details
Judith
Landman-Parker
Speaker details
Andrew
Lister
Speaker details
Elly
Lugtenburg
Speaker details
Lütgendorf-Caucig
Speaker details
Robert
Marcus
Speaker details
Carmen
Martinez
Speaker details
Stephan
Mathas
Speaker details
Christine
Mauz-Körholz
Speaker details
Michel
Meignan
Speaker details
Franck
Morschhauser
Speaker details
Andrea
Ng
Speaker details
Michael
O'Doherty
Speaker details
Karl
Peggs
Speaker details
Stefano
Pileri
Speaker details
Aaron
Polliack
Speaker details
John
Radford
Speaker details
John
Raemaekers
Speaker details
Simon
Richardson
Speaker details
Luigi
Rigacci
Speaker details
Andreas
Rimner
Speaker details
Andreas
Rosenwald
Speaker details
Mathias
Rummel
Speaker details
Filippo
Russo
Speaker details
Gilles
Salles
Speaker details
Christoph
Scheid
Speaker details
Norbert
Schmitz
Speaker details
Cindy L.
Schwartz
Speaker details
Margaret
Shipp
Speaker details
Reiner
Siebert
Speaker details
Lena
Specht
Speaker details
Michele
Spina
Speaker details
Jens
Stanelle
Speaker details
Christian
Steidl
Speaker details
Harald
Stein
Speaker details
Anna
Sureda
Speaker details
Staphanie
Terezakis
Speaker details
Marek
Trnĕný
Speaker details
Anke
van den Berg
Speaker details
Flora
van Leeuwen
Speaker details
Jan
Walewski
Speaker details
Clemens
Wendtner
Speaker details
Andrew
Wirth
Speaker details
Thomas
Wirth
Speaker details
Joachim
Yahalom
Speaker details
Anas
Younes
Speaker details
Harald
zur Hausen
Basement
shift key
Hold SHIFT key while scrolling to zoom the map.
Hold ALT key while scrolling to rotate the map.
pinch-gesture
Use two fingers to zoom, move, or rotate the map.
Floor plan of Basement
Wardrobe
Go to Ground Floor
Go to Ground Floor
Weinkeller
Basement
First Floor
shift key
Hold SHIFT key while scrolling to zoom the map.
Hold ALT key while scrolling to rotate the map.
pinch-gesture
Use two fingers to zoom, move, or rotate the map.
Floor plan of First Floor
Go to Ground Floor
Go to Ground Floor
Großer Saal
First Floor
Dorint Hotel: Ground Level
shift key
Hold SHIFT key while scrolling to zoom the map.
Hold ALT key while scrolling to rotate the map.
pinch-gesture
Use two fingers to zoom, move, or rotate the map.
Floor plan of Dorint Hotel: Ground Level
Go to Ground Floor
Go to Ground Floor
Go to First Floor
Pipin II
Sandkaul
Pipin I
Pfau
Dorint Hotel: Ground Level
Dorint Hotel: First Floor
shift key
Hold SHIFT key while scrolling to zoom the map.
Hold ALT key while scrolling to rotate the map.
pinch-gesture
Use two fingers to zoom, move, or rotate the map.
Floor plan of Dorint Hotel: First Floor
Go to Ground Level
Martin
&
Augustin
Severin
Dorint Hotel: First Floor
Exhibition
shift key
Hold SHIFT key while scrolling to zoom the map.
Hold ALT key while scrolling to rotate the map.
pinch-gesture
Use two fingers to zoom, move, or rotate the map.
Map of the exhibition.
Map of the First Floor showing the location of 0 exhibitors.
Stair to Ground Floor
Stair to Ground Floor
Großer Saal